- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Lipids
Volume 2012 (2012), Article ID 587479, 7 pages
Lipid Peroxidation and Paraoxonase-1 Activity in Celiac Disease
1Dipartimento di Scienze Cliniche Sperimentali e Odontostomatologiche, Università Politecnica delle Marche, 60131 Ancona, Italy
2Dipartimento di Scienze della Vita e dell'Ambiente, Università Politecnica delle Marche, 60131 Ancona, Italy
3Clinica di Gastroenterologia, Università Politecnica delle Marche, 60131 Ancona, Italy
Received 1 December 2011; Revised 16 January 2012; Accepted 19 January 2012
Academic Editor: Bianca Fuhrman
Copyright © 2012 Gianna Ferretti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. Shan, O. Molberg, I. Parrot et al., “Structural basis for gluten intolerance in celiac Sprue,” Science, vol. 297, no. 5590, pp. 2275–2279, 2002.
- B. Diosdado, E. van Oort, and C. Wijmenga, “‘Coelionomics’: towards understanding the molecular pathology of coeliac disease,” Clinical Chemistry and Laboratory Medicine, vol. 43, no. 7, pp. 685–695, 2005.
- F. Koning, D. Schuppan, N. Cerf-Bensussan, and L. M. Sollid, “Pathomechanisms in celiac disease,” Best Practice and Research, vol. 19, no. 3, pp. 373–387, 2005.
- P. H. R. Green, K. Rostami, and M. N. Marsh, “Diagnosis of coeliac disease,” Best Practice and Research, vol. 19, no. 3, pp. 389–400, 2005.
- P. Odetti, S. Valentini, I. Aragno et al., “Oxidative stress in subjects affected by celiac disease,” Free Radical Research, vol. 29, no. 1, pp. 17–24, 1998.
- V. Stojiljković, A. Todorović, N. Radlović et al., “Antioxidant enzymes, glutathione and lipid peroxidation in peripheral blood of children affected by coeliac disease,” Annals of Clinical Biochemistry, vol. 44, no. 6, pp. 537–543, 2007.
- K. K. Hozyasz, M. Chelchowska, and T. Laskowska-Klita, “Vitamin E levels in patients with celiac disease,” Medycyna Wieku Rozwojowego, vol. 7, no. 4, pp. 593–604, 2003.
- V. Stojiljković, A. Todorović, S. Pejić et al., “Antioxidant status and lipid peroxidation in small intestinal mucosa of children with celiac disease,” Clinical Biochemistry, vol. 42, no. 13-14, pp. 1431–1437, 2009.
- A. Szaflarska-Poplawska, A. Siomek, M. Czerwionka-Szaflarska et al., “Oxidatively damaged DNA/oxidative stress in children with celiac disease,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 8, pp. 1960–1965, 2010.
- L. Högberg, C. Webb, K. Fälth-Magnusson et al., “Children with screening-detected coeliac disease show increased levels of nitric oxide products in urine,” Acta Paediatrica, vol. 100, no. 7, pp. 1023–1027, 2011.
- M. I. Mackness, S. Arrol, C. Abbott, and P. N. Durrington, “Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase,” Atherosclerosis, vol. 104, no. 1-2, pp. 129–135, 1993.
- B. MacKness and M. MacKness, “Anti-inflammatory properties of paraoxonase-1 in atherosclerosis,” Advances in Experimental Medicine and Biology, vol. 660, pp. 143–151, 2010.
- B. Goswami, D. Tayal, N. Gupta, and V. Mallika, “Paraoxonase: a multifaceted biomolecule,” Clinica Chimica Acta, vol. 410, no. 1-2, pp. 1–12, 2009.
- B. Mackness, P. Durrington, P. McElduff et al., “Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study,” Circulation, vol. 107, no. 22, pp. 2775–2779, 2003.
- G. Ferretti, T. Bacchetti, S. Masciangelo et al., “Lipid peroxidation in stroke patients,” Clinical Chemistry and Laboratory Medicine, vol. 46, no. 1, pp. 113–117, 2008.
- G. Ferretti, T. Bacchetti, S. Masciangelo, and V. Bicchiega, “HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects,” Obesity, vol. 18, no. 6, pp. 1079–1084, 2010.
- G. Ferretti, T. Bacchetti, D. Busni, R. A. Rabini, and G. Curatola, “Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2957–2962, 2004.
- L. Rothem, C. Hartman, A. Dahan, J. Lachter, R. Eliakim, and R. Shamir, “Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum,” Free Radical Biology and Medicine, vol. 43, no. 5, pp. 730–739, 2007.
- D. Boehm, M. Krzystek-Korpacka, K. Neubauer et al., “Paraoxonase-1 status in Crohn's disease and ulcerative colitis,” Inflammatory Bowel Diseases, vol. 15, no. 1, pp. 93–99, 2009.
- G. Baskol, M. Baskol, A. Yurci, O. Ozbakir, and M. Yucesoy, “Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis,” Cell Biochemistry and Function, vol. 24, no. 3, pp. 283–286, 2006.
- M. N. Marsh, “Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”),” Gastroenterology, vol. 102, no. 1, pp. 330–354, 1992.
- A. Bürgin-Wolff, I. Dahlbom, F. Hadziselimovic, and C. J. Petersson, “Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease,” Scandinavian Journal of Gastroenterology, vol. 37, no. 6, pp. 685–691, 2002.
- W. Rock, M. Rosenblat, R. Miller-Lotan, A. P. Levy, M. Elias, and M. Aviram, “Consumption of Wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities,” Journal of Agricultural and Food Chemistry, vol. 56, no. 18, pp. 8704–8713, 2008.
- A. Kontush and U. Beisiegel, “Measurement of oxidizability of blood plasma,” Methods in Enzymology, vol. 299, pp. 35–49, 1998.
- B. Ou, M. Hampsch-Woodill, and R. L. Prior, “Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe,” Journal of Agricultural and Food Chemistry, vol. 49, no. 10, pp. 4619–4626, 2001.
- M. Rosenblat and M. Aviram, “Paraoxonases role in the prevention of cardiovascular diseases,” Biofactors, vol. 35, no. 1, pp. 98–104, 2009.
- L. G. Costa, A. Vitalone, T. B. Cole, and C. E. Furlong, “Modulation of paraoxonase (PON1) activity,” Biochemical Pharmacology, vol. 69, no. 4, pp. 541–550, 2005.
- O. Khersonsky and D. S. Tawfik, “Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase,” Biochemistry, vol. 44, no. 16, pp. 6371–6382, 2005.
- R. Rivabene, E. Mancini, and M. de Vincenzi, “In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: implications for coeliac disease,” Biochimica et Biophysica Acta, vol. 1453, no. 1, pp. 152–160, 1999.
- L. Elli, E. Dolfini, and M. T. Bardella, “Gliadin cytotoxicity and in vitro cell cultures,” Toxicology Letters, vol. 146, no. 1, pp. 1–8, 2003.
- P. Bergamo, M. Gogliettino, G. Palmieri et al., “Conjugated linoleic acid protects against gliadin-induced depletion of intestinal defenses,” Molecular Nutrition and Food Research, vol. 55, supplement 2, pp. S248–S256, 2011.
- R. W. James and S. P. Deakin, “The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity,” Free Radical Biology and Medicine, vol. 37, no. 12, pp. 1986–1994, 2004.
- J. K. Kruit, A. K. Groen, T. J. van Berkel, and F. Kuipers, “Emerging roles of the intestine in control of cholesterol metabolism,” World Journal of Gastroenterology, vol. 12, no. 40, pp. 6429–6439, 2006.
- L. P. Precourt, E. Seidman, E. Delvin et al., “Comparative expression analysis reveals differences in the regulation of intestinal paraoxonase family members,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 7, pp. 1628–1637, 2009.
- R. Shamir, C. Hartman, R. Karry et al., “Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2,” Free Radical Biology and Medicine, vol. 39, no. 3, pp. 336–344, 2005.
- B. Mackness, R. Beltran-Debon, G. Aragones, J. Joven, J. Camps, and M. Mackness, “Human tissue distribution of paraoxonases 1 and 2 mRNA,” IUBMB Life, vol. 62, no. 6, pp. 480–482, 2010.
- M. Aviram, M. Rosenblat, S. Billecke et al., “Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants,” Free Radical Biology and Medicine, vol. 26, no. 7-8, pp. 892–904, 1999.
- S. D. Nguyen, N. D. Hung, P. Cheon-Ho, K. M. Ree, and S. Dai-Eun, “Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1),” Biochimica et Biophysica Acta, vol. 1790, no. 3, pp. 155–160, 2009.
- E. Niki, “Lipid peroxidation: physiological levels and dual biological effects,” Free Radical Biology and Medicine, vol. 47, no. 5, pp. 469–484, 2009.